Answer
The total systemic bioavailability of inhaled ipratropium bromide monohydrate is estimated at 7–28%.
Sources for this answer
- Atrovent Inhaler CFC-FreeBoehringer Ingelheim Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 13Document updated
Sources checked